Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17

James N. Ingle, D. Tu, J. L. Pater, H. B. Muss, S. Martino, N. J. Robert, M. J. Piccart, M. Castiglione, L. E. Shepherd, K. I. Pritchard, R. B. Livingston, N. E. Davidson, L. Norton, E. A. Perez, J. S. Abrams, D. A. Cameron, M. J. Palmer, P. E. Goss

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17'. Together they form a unique fingerprint.

Medicine & Life Sciences